GGrantIndex
← Search

MOLECULAR TARGETING OF PROSTATE CANCER DURING ANDROGEN ABLATION: INHIBITION OF CHES1/FOXN3

$572,887FY2009Department of DefenseDOD

University Of California, Davis

Investigators

View source on USAspending →
MOLECULAR TARGETING OF PROSTATE CANCER DURING ANDROGEN ABLATION: INHIBITION OF CHES1/FOXN3 · GrantIndex